跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 79,052 条关于
“JAK1/2 inhibitor”
全部
79,052
临床试验
50,080
药物
10,833
机构
1,402
资讯
16,737
去年
JAK Inhibitors Show Promise in Treating Alopecia Areata
去年
JAK Inhibitors Reduce Thromboembolic Risk in Myeloproliferative Neoplasms Through Novel Mechanisms
去年
New Phase 1 Trial Combines Tagraxofusp and Pacritinib for Treatment-Resistant Myelofibrosis
去年
FDA Approval of Axatilimab Marks New Era in Chronic GVHD Treatment
去年
Pfizer's Litfulo Becomes First NHS-Approved Treatment for Severe Alopecia Areata
去年
Accropeutics' Oral TYK2/JAK1 Inhibitor Shows Strong Efficacy in Phase 2 Psoriasis Trial
2个月前
Sareum Completes Dosing in Phase 2-Enabling Toxicology Programme for TYK2/JAK1 Inhibitor SDC-1801
去年
Sun Pharma Launches Deuruxolitinib for Severe Alopecia Areata in US Market
3个月前
JAK-STAT1-MED15 Axis Drives Melanocyte Dysfunction in Vitiligo, Study Reveals
4年前
Ruxolitinib Plus Steroids Shows Superior Early Response in First-Line Acute GVHD Treatment
第 1 页,共 1674 页
上一页
下一页